Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1651-1660 of 1755 for cancer

Edit search filters
  1. A Study Of Women Having Screening Mammography At Mayo Clinic To Develop A Better Way To Predict Risks For Cancer

    Rochester, MN

  2. Myeloma Referral Study (Race, Ethnicity, and Familial Etiologic Relationship, Risk Association, and Linkage Study)

    Rochester, MN

  3. Post-Surgical Based Efforts to Reduce Preventable Readmissions and Optimize Length of Stay

    Rochester, MN

  4. Patient Adherence and Symptoms During Post-operative Fluid Restriction Protocol After Transsphenoidal Surgery

    Jacksonville, FL

  5. Transbronchial Biopsy Assisted By Robot Guidance In The Evaluation Of Tumors Of The Lung

    Scottsdale/Phoenix, AZ

  6. A Study Of The Gut Microbiome In Chemotherapy Treatment

    Rochester, MN

  7. A Study To Detect Cancers Through Elective Plasma-based CancerSEEK Testing

    Albert Lea, MN, Scottsdale/Phoenix, AZ, Eau Claire, WI, La Crosse, WI, Mankato, MN, Rochester, MN

  8. CfDNA With Natera

    Rochester, MN

  9. A Study To Assess Dynamic Changes In Plasma Proteome To Identify Early Detection And Treatment Response Biomarkers For HGSOC

    Rochester, MN

  10. A Study To Evaluate Circulating Cell Free Tumor DNA As A Biomarker In Sarcoma

    Rochester, MN

.

Mayo Clinic Footer